Osteoporosis Management

Osteoporosis is a treatable disease, but not a curable one. There are different types of treatment for osteoporosis. Some of the medications that can be taken for treatment of osteoporosis are estrogen, bisphosphonates, calcitionin, raloxifene, parathyroid hormone, and testosterone replacement (UCSF Medical Center, 2010). Some of the more common names for bisphosphonates are Fosamax, Actonel, Boniva, and Reclast (Mayo Clinic, 2009). These treatments are taken orally once a week or once a month. In addition to the medications, there is also the treatment of exercise and diet. With a diet high in calcium, stopping unhealthy habits, like smoking and drinking, and regular exercise can reduce the likelihood of bone fractures in people with osteoporosis (The New York Times, 2010). In Ms. Duckworth’s incident, it would be recommended that she increase the amount of calcium in her diet and exercise, and depending on the severity of the osteoporosis, medication.

As generally stated in the introduction, osteoporosis is a skeletal disorder that involves the strength and integrity of one’s bones. The WHO defines osteoporosis as, “a systemic skeletal disorder characterized by low-bone mass, deterioration of bone tissue, increased bone fragility, and its susceptibly to recurrent fractures.” 2 The most important factor to take into account when addressing osteoporosis is the mass of bone, also referred to as, bone mineral density (BMD). As bone mass begins to decline, typically in the older population, specifically postmenopausal women, individuals are at an increased risk for fractures.3 As a result of this serious condition, many people are affected by morbidity, mortality, and economic difficulty.1

Osteoporosis is a degenerative disease of the bones generally brought on by the process of aging, unfortunately there can also be a number of underlying or secondary causes; however, preventative care and drug treatments can minimize the severity of this prevalent disease. Osteoporosis has been estimated to affect more than 200 million people worldwide (Bethel, 2015). According to the National Osteoporosis Foundation, 9.9 million Americans have osteoporosis and an additional 43.1 million have low bone density.

Slowing the rate of calcium and bone loss, therefore stopping the disease processes are the goals in the treatment of osteoporosis. Medications should be considered from the following selections. Bisphosphonates (e.g. alendronate, etidronate, risedronate, zoledronic acid) are the medications of choice for treating osteoporosis. Bisphosphonates help decrease the bone destruction by inhibiting hydroxyapatite breakdown, and increase bone mineralization, therefore increasing bone density (Medical Services

A disease of long duration is a chronic disease. Osteoporosis is considered chronic and this paper will discuss what it means, what the risk factors and who is affected, this paper will address the symptoms to look out for and when to go to the doctor. Nutrition and what proper exercise can do to help prevent or slow down the progression caused by osteoporosis, and then the paper will list prevention and treatment options. May is osteoporosis month and this encourages free screenings for those who may have chances for osteoporosis!

in the lowest position while in bed as well as having both side rails up can be courses of

Osteoporosis is an age related disorder, more common in females compared to males. Osteoporosis is defined as a “skeletal disorder characterized by compromised bone strength predisposing to increased risk of fractures (Manolagaas, 2014). Osteoporosis is defined as “a disease characterized by low bone mass and deterioration of bone tissue (What is osteoporosis?2014). Osteoporosis is sometimes also referred as “silent thief” as the bone loss occurs very slowly and silently without any symptoms (Osteoporosis facts & statistics.2014). The most common site for fracture due to osteoporosis is hip followed by humerus (Woltman & den Hoed, 2010) . Osteoporosis can occur at any age, although it is a disorder common in females (especially post-menopausal females). Everyone is prone to osteoporosis (Osteoporosis facts & statistics.2014). According to Osteoporosis Canada, 1 in 3 Canadian females and 1 in 5 Canadian males may suffer fractures due to osteoporosis during their lifetime (Osteoporosis facts & statistics.2014). Canadian health care system spends 1.2 billion dollars for the acute hospitalization caused by osteoporosis and in 2010 the health care system spent 3.9 billion dollars for the total treatment of osteoporosis (Osteoporosis facts & statistics.2014). Osteoporosis can be screened and diagnosed by various methods; however the dual energy x ray absorptiometry (DXA) is commonly used. If the T-score values are less than -1 and greater than -2.5SD it is termed as osteopenia,

Osteoporosis is a major public heath treat for more than 28 million Americans, 80 percent of whom are women. In the U.S. today, 10 million individuals

Osteoporosis is a disease of bone that leads to an increased risk of fracture. In osteoporosis the bone mineral density (BMD) is reduced, bone microarchitecture is disrupted, and the amount and variety of non-collagenous proteins in bone is altered. Osteoporosis is defined by the World Health Organization (WHO) in women as a bone mineral density 2.5 standard deviations below peak bone mass (20-year-old healthy female average) as measured by DXA; the term "established osteoporosis" includes the presence of a fragility fracture.[1] Osteoporosis is most common in women after menopause, when it is called postmenopausal osteoporosis, but may also develop in men, and may occur in anyone in the presence of particular hormonal

The term osteoporosis describes bone loss that is extensive enough to increase the risk of fracture. The term is a general one, not related to any specific cause for the bone loss. Nearly all people with OI have osteoporosis, because they do not develop appropriate bone mass at any age. Women and men with OI can experience additional bone loss, such as age-related bone loss, superimposed on a background of OI. Symptoms of additional bone loss may appear at a younger age than commonly seen in people who don’t have

Osteoporosis is a common health concern globally. It has been estimated that 1 in 3 women in the United States suffers from osteoporosis and related fractures after menopausal age. According to the existing evidence, elderly patients have received inefficient attention regarding osteoporosis prevention or treatment. Moreover, physicians have practiced insufficiently in the prescription of anti-osteoporosis medication. Since the condition has a silent progressive process and presents with debilitating fractures, prompt diagnosis is of crucial importance to prevent morbidity and mortality.

It is the choice of the diagnosed to the medication or opt for alternative therapies. There are various medications for osteoporosis these help to reduce the amount of bone lost. There are five types of medication they include Bisphosphonates, Strontium ranelate, Monoclonal antibodies, Hormone replacement therapy, and Selective oestrogen receptor modulators. There is also many different ways of treatment that do not require drugs. Some herbs and supplements have are suspected to decrease or even the stop bone loss caused by osteoporosis, such as Red Clover, Soy, and Black Cohosh. All of these are believed to contain oestrogen-like compounds as oestrogen can naturally protect the bones. Accoutre puncture and Tai Chi may also be used as alternative therapies. The National Center for Complementary and Alternative Medicine suggest that tai chi might be able to promote increased immune function and overall well being for older adults. It is also suggested to improve strength and coordination, and also reduces muscle or joint pain along with

According to Osteoporosis (2011) “United States has the highest rate in the world in cases of osteoporosis. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) estimates that 10 million people (8 million women and 2 million men) in the United States have osteoporosis as of 2012” (Page 10).

Studies have shown that both estrogen and raloxifene, a Selective Estrogen Receptor Modulator, can prevent the loss of bone mass in postmenopausal women. Alendronate, a bisphosphonate is an alternative to estrogen for bone protection. Calcitonin is another treatment used by women for osteoporosis. This drug has been shown to slow bone breakdown and also may reduce the pain associated with osteoporotic fractures. Treatments under investigation include other bisphosphonates, sodium fluoride, para-thyroid hormone, vitamin D metabolites, and other selective estrogen receptor modulators.

Osteoporosis is described by the NHS as “a condition that weakens bones” and is fairly common, affecting roughly 3 million, with more than 300,000 people receiving treatment each year. Fractures are extremely common as the weakened bones are more susceptible to damage, even coughing may cause vertebral damage. Osteoporosis can be classified as type I or II, “both type I and type II osteoporosis occur through an imbalance between total skeletal bone formation and bone resorption which is sustained over many years” (Theobald, 2005), and are related to a lack of vitamin